What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Dopamine
Deniz Kirik mostly deals with Neuroscience, Substantia nigra, Striatum, Dopamine and Parkinson's disease.
He interconnects Subventricular zone, Rostral migratory stream and Transplantation in the investigation of issues within Neuroscience.
His Substantia nigra research is multidisciplinary, relying on both Glial cell line-derived neurotrophic factor, Alpha-synuclein and Cell biology.
Deniz Kirik has included themes like Lesion, Globus pallidus and Oxidopamine in his Striatum study.
His Dopamine research integrates issues from Axoplasmic transport and Neuron.
Deniz Kirik has researched Parkinson's disease in several fields, including Cell therapy, Nucleus basalis, Microglia and Immunology.
His most cited work include:
- Neuronal replacement from endogenous precursors in the adult brain after stroke (2409 citations)
- Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. (582 citations)
- Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat (568 citations)
What are the main themes of his work throughout his whole career to date?
Neuroscience, Dopamine, Parkinson's disease, Striatum and Substantia nigra are his primary areas of study.
The study incorporates disciplines such as Glial cell line-derived neurotrophic factor, Neurotrophic factors and Neurodegeneration in addition to Neuroscience.
His work in Dopamine covers topics such as Serotonin which are related to areas like Neurotransmitter.
His study looks at the relationship between Parkinson's disease and fields such as Genetic enhancement, as well as how they intersect with chemical problems.
His Striatum research is multidisciplinary, relying on both Lesion, Transduction and Oxidopamine.
His Substantia nigra research is multidisciplinary, incorporating perspectives in Ventral tegmental area, Axoplasmic transport and Midbrain.
He most often published in these fields:
- Neuroscience (45.45%)
- Dopamine (35.35%)
- Parkinson's disease (31.82%)
What were the highlights of his more recent work (between 2015-2021)?
- Alpha-synuclein (17.68%)
- Neurodegeneration (16.16%)
- Cell biology (14.65%)
In recent papers he was focusing on the following fields of study:
Deniz Kirik focuses on Alpha-synuclein, Neurodegeneration, Cell biology, Phosphorylation and Striatum.
His research in Alpha-synuclein intersects with topics in Fibril and Dopaminergic.
His study in Neurodegeneration is interdisciplinary in nature, drawing from both Neuroscience, Parkinsonism, In vivo and Green fluorescent protein.
His Neuroscience study frequently draws parallels with other fields, such as Atrophy.
Internal medicine, Endocrinology and Dopamine are the two main areas of interest in his Striatum studies.
His work carried out in the field of Substantia nigra brings together such families of science as Glial cell line-derived neurotrophic factor, Ventral tegmental area and Midbrain.
Between 2015 and 2021, his most popular works were:
- How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease? (54 citations)
- How is alpha-synuclein cleared from the cell? (38 citations)
- Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands (31 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neuron
Deniz Kirik mainly investigates Alpha-synuclein, Viral vector, Cell biology, Neurotrophic factors and Fibril.
His research integrates issues of In vivo and Phosphorylation in his study of Alpha-synuclein.
His studies in Viral vector integrate themes in fields like Neurodegeneration and Green fluorescent protein.
His Neurotrophic factors study combines topics in areas such as Endocrinology, Genetic enhancement and Huntingtin.
The concepts of his Hyperphosphorylation study are interwoven with issues in Neuroscience and Parkinson's disease.
His studies deal with areas such as Dopaminergic and Dopamine as well as Parkinson's disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
